Successful nanolitre real-time PCR detection of respiratory pathogens in clinical specimens  by Slinger, R. et al.
Successful nanolitre real-time PCR
detection of respiratory pathogens in
clinical specimens
R. Slinger1,2, I. Moldovan1, N. Barrowman1,2,3 and F. Chan1,2
1) Children’s Hospital of Eastern Ontario, 2) University of Ottawa, and
3) CHEO Research Institute, Ottawa, ON, Canada
Abstract
We performed a proof-of-concept study to determine if human
pathogens could be detected in clinical specimens using nanolitre-
volume real-time PCR. Nanolitre PCR for Bordetella pertussis/
B. parapertussis and respiratory syncytial virus (RSV) was per-
formed on nasopharyngeal specimens and results compared with
conventional methods. B. pertussis/B. parapertussis nanolitre PCR
detection was 100% sensitive (20/20; 95% CI, 84–100%) and
100% specific (26/26; 95% CI, 87–100%). RSV nanolitre PCR was
also 100% sensitive (21/21; 95% CI, 85–100%) and specific (25/
25; 95%, CI 87–100%). Respiratory pathogens can be successfully
detected in clinical specimens using nanolitre-volume PCR.
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A nanolitre-volume real-time PCR platform is commercially
available (OpenArray Real-Time PCR System, Life Technol-
ogies, Carlsbad, CA, USA) in which individual 33 nanolitre
real-time PCR reactions are performed in through-holes in a
microscope-slide sized steel plate [1]. Over 3000 nanolitre
PCR reactions can be performed on a single plate, making
this platform potentially useful for detection of multiple tar-
gets simultaneously.
To our knowledge, the use of this platform for detection
of human infectious disease agents in clinical specimens has
not yet been described [2]. We therefore undertook a
proof-of concept study to assess the ability of the nanolitre
PCR system to detect pathogenic microorganisms in human
clinical specimens.
We chose to study detection of the bacterial respiratory
pathogens Bordetella pertussis, the cause of whooping cough,
and B. parapertussis, which causes a similar illness, and the
virus respiratory syncytial virus (RSV). RSV is the major
cause of bronchiolitis and viral pneumonia in infants and
young children.
We compared nanolitre PCR detection results for these
organisms with those obtained with standard detection
methods. We considered the standard methods as the refer-
ence methods for statistical analysis. The reference methods
for Bordetella spp. detection were published microlitre-vol-
ume 5¢exonuclease real-time PCR assays for insertion
sequence IS481 of B. pertussis and IS1001 of B. parapertussis
[3]. For RSV detection, the reference method was immuno-
fluorescent antibody (FA) detection [4].
Our main outcome measures were the sensitivity and
specificity of the nanolitre PCR assays compared with the
reference method results. For B. pertussis and B. parapertussis,
we also compared cycle threshold (Ct) values for nanolitre
and microlitre-volume real-time PCR assays.
Nucleic acid extraction was performed on residual aliqu-
ots of nasopharyngeal aspirate (NPA) specimens that would
otherwise have been discarded. These specimens were made
anonymous, with only the nanolitre PCR and standard test
results recorded. DNA extractions for B. pertussis testing
were performed on NPA specimens using the PrepMan Ultra
reagent (Life Technologies). Extracted DNA was saved at
)80C until PCR testing. RNA extraction for RSV testing
was performed using an automated method (iPrep Purifica-
tion Instrument, Life Technologies) following the manufac-
turer’s protocol with an elution volume of 20 lL. RNA was
then converted to cDNA using the SuperScript VILO
cDNA Synthesis Kit (Life Technologies) and cDNA was
saved at )80C.
For nanolitre PCR testing, we used the same Bordetella
spp. PCR assays as used in the microlitre-volume reference
method. For RSV nanolitre PCR, published 5¢exonuclease
assays specific for RSV subtype A and B were used [5].
Nanolitre PCR plates with these assays dried-down in the
through-holes were prepared by the manufacturer and
shipped to us for testing.
Nanolitre PCR was performed following the manufac-
turer’s recommendations. A PCR master-mix was prepared
and aliquoted into wells in a 384-well plate, and 1.2 lL of
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sample DNA or cDNA were added to the master-mix. This
mixture was then distributed into the plate through-holes
using the auto-loader device supplied with the thermocycler.
The loaded plate was then inserted into a glass slide case
filled with an inert fluid. The top of the slide case was cov-
ered with UV glue that was then cured with UV light to cre-
ate a closed PCR amplification chamber. The plate was then
placed in the nanolitre PCR thermocycler and the preset
thermocycling protocol was begun, taking approximately
2.5 h to complete. The cycle threshold (Ct) values were
recorded and analysed.
Standard volume PCR for B. pertussis and B. parapertussis
was performed in 25 microlitre volumes on an AB 7500
thermocycler (Life Technologies). RSV FA was performed as
previously described [4].
Forty-six NPA specimens were tested for B. pertussis and
B. parapertussis by nanolitre PCR. These consisted of: 16
specimens positive for B. pertussis, four positive for B. par-
apertussis, and 26 specimens negative for both B. pertussis and
B. parapertussis by the reference method. For the RSV assay
comparisons, 46 samples were also studied, consisting of 21
specimens positive for RSV by FA and 25 RSV FA-negative
specimens.
Examples of B. pertussis and RSV nanolitre PCR amplifica-
tion curves are shown in Figure 1. The results of nanolitre
PCR as compared with the reference methods are shown in
Table 1. The sensitivity of nanolitre PCR for the detection of
B. pertussis/B. parapertussis was 100% (20/20, 95% CI 84–
100% using the Wilson score method) and it also was100%
specific (26/26, 95% CI 87–100%) compared with the refer-
ence method. Similarly, RSV detection by nanolitre PCR was
also 100% sensitive (21/21; 95%, CI 85–100%) and specific
(25/25; 95% CI, 87–100%) as compared with FA testing.
Comparison of Ct values for the nanolitre and standard
volume PCR for the 16 B. pertussis- positive specimens
showed a mean Ct of 16.39 (range 10.81–28.07) with nanoli-
tre PCR and a mean Ct of 19.61 (range 15.29–29.37) with
standard volume PCR. For the four B. parapertussis-positive
specimens, the mean nanolitre PCR Ct was 20.28 (range
14.29–25.07) and standard volume PCR was 21.48 (range
16.28–25.30). For the nanolitre PCR RSV A assay, the mean
Ct value was 29.31, with a range of 22.55–35.36 cycles. For
the RSV B assay, the mean Ct value was 27.53, with a range
of 23.05–30.58 cycles.
This study demonstrates for the first time that the nanoli-
tre real-time PCR platform used is capable of detecting
human infectious disease agents in clinical specimens. Our
study is limited by being retrospective in nature and having a
relatively small sample size, but because both the bacterial
and viral target organisms were accurately detected as com-
pared with the reference methods, we believe additional lar-
ger prospective studies of infectious disease applications of
nanolitre real-time PCR are warranted. For example, the
ability of this system to perform several thousand individual
real-time PCRs in a single run may make this platform a
FIG. 1. Examples of nanolitre PCR amplifica-
tion curves showing detection of respiratory
syncytial virus (RSV) type A (left panel) and
B. pertussis (right panel) from nasopharyngeal
aspirate specimens.
TABLE 1. Comparison of nanolitre PCR and conventional
methods for detection of Bordetella species (spp.) and respi-
ratory syncytial virus (RSV)
Bordetella spp. standard method
(microlitre-volume PCR)
Positive Negative
Bordetella spp. nanolitre PCR
Positive 20a 0
Negative 0 26
RSV conventional method
(immunofluorescent antibody)
Positive Negative
RSV nanolitre PCR
Positive 21 0
Negative 0 25
aThis consisted of 16 B. pertussis-positive specimens and 4 B. parapertussis-posi-
tive specimens.
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useful tool for infectious disease outbreak investigation or
large-scale epidemiological studies.
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